journal article Oct 10, 2016

Polymorphism in Pharmaceutical Drugs by Supercritical CO2 Processing: Clarifying the Role of the Antisolvent Effect and Atomization Enhancement

View at Publisher Save 10.1021/acs.cgd.6b00697
Topics

No keywords indexed for this article. Browse by subject →

References
22
[1]
Charbit, G.; Boutin, O.; Badens, E.InSupercritical Fluid Technology for Drug Product Development;York, P., Kompella, U. B., Shekunov, B. Y., Eds.; Drugs and the Pharmaceutical Sciences;Informa Healthcare:New York, 2004; Vol.138, Chapter 4, pp152–158.
[18]
Measurement and modelling of the solubility of solids in mixtures of common solvents and compressed gases

F.E. Wubbolts, O.S.L. Bruinsma, G.M. van Rosmalen

The Journal of Supercritical Fluids 10.1016/j.supflu.2004.02.004
Metrics
32
Citations
22
References
Details
Published
Oct 10, 2016
Vol/Issue
16(11)
Pages
6222-6229
Funding
European Regional Development Fund
Fundação para a Ciência e a Tecnologia Award: IF/01183/2013
Cite This Article
Miguel A. Rodrigues, João M. Tiago, Andreia Duarte, et al. (2016). Polymorphism in Pharmaceutical Drugs by Supercritical CO2 Processing: Clarifying the Role of the Antisolvent Effect and Atomization Enhancement. Crystal Growth & Design, 16(11), 6222-6229. https://doi.org/10.1021/acs.cgd.6b00697
Related

You May Also Like